Navigation Links
Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
Date:1/17/2011

Ebersberg, Germany, January 17, 2011 Eurofins MWG Operon, international market leader and expert for DNA sequencing, has signed a 2-year contract to supply DNA sequencing services to the Research Councils UK Shared Services Ltd (RCUK SSC Ltd). The contract may be extended to 3 years, and builds on a 5-year relationship developed as a preferred supplier of synthetic DNA and RNA oligonucleotides to the Research Councils.

RCUK SSC Ltd has been set up by the seven Research Councils of the UK (RCUK) to provide centralised services to the Research Councils and their institutes in human resources (HR), finance, procurement, Information Technology, Information Systems and grants processing. The shared service approach reduces costs whilst raising operational efficiency for the Councils.

"We are pleased to have the opportunity to further develop our relationship with RCUK. This contract will allow us to demonstrate our competence and strength in genomic services beyond the provision of synthetic DNA and RNA oligonucleotides", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "The synergies across our service offerings allow us to optimize our client service, from ordering convenience, to streamlined processes, through to faster turnaround time."

Richard Fowles, Category Manager at RCUK SSC Ltd commented, "RCUK SSC Ltd is pleased to announce the selection of Eurofins as one of its preferred suppliers of DNA sequencing services. Eurofins is already a proven supplier of oligos and we believe this new contract will afford them opportunities to further enhance their already strong reputation."

Eurofins MWG Operon also provides best in class next generation sequencing services, siRNA and gene synthesis services and is committed to continually optimizing and improving processes and product quality to ensure that they deliver their products and services in the fastest and most convenient manner possible.


'/>"/>

Contact: Dr. Jutta Huber
juttahuber@eurofins.com
49-809-282-89930
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Eurofins MWG Operon adds Roche GS Junior to its sequencer fleet
2. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. Eurofins MWG Operon and Genomatix launch strategic alliance
5. Verizon Business to Provide Global IP for Eurofins Scientific
6. Reading the signs: Plants and animals found common ground in response to microbial threats
7. China PharmaHub Signs Distribution Agreement with Integrated Biometrics
8. Studying the metabolome of smokers, Lombardi researchers find early signs of damage
9. Speed installation of system to monitor vital signs of global ocean, scientists urge
10. SailPoint Signs International Reseller Agreement with BMC Software
11. Road signs and traffic signals on DNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
(Date:12/15/2016)... , Dec. 15, 2016 Advancements ... experience, health wellness and wellbeing (HWW), and ... in three new passenger vehicles begin to ... gesture recognition, heart beat monitoring, brain wave ... facial monitoring, and pulse detection. These will ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017   Pulmatrix, Inc . ... company developing innovative inhaled therapies to address serious pulmonary ... fungal infections in the lungs of CF patients, PUR1900, ... (QIDP) by the U.S. Food & Drug Administration. ... designed to speed the development of novel drugs against ...
(Date:1/17/2017)... , Jan. 17, 2017  Only nine percent of ... over profits, while only 16 percent believe health insurance ... today. Meanwhile, 36 percent of U.S. adults believe health ... over profits, compared to hospitals (23%). "We ... said Wendy Salomon , vice president of reputation ...
(Date:1/17/2017)... Jose, CA (PRWEB) , ... January 17, 2017 , ... ... cultivate a balanced, peaceful and healthy lifestyle, announced today the official launch of its ... and frees the mind. , In development for over a year, the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, a ... announced a collaboration with the Heidelberg University Hospital and the German Cancer Research ... following the company’s successful launch of its CATS (Capture and Amplification by ...
Breaking Biology Technology: